Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (841-850 of 934) with videos related to

Pageof 94
Sort By:
Circulation|October 4, 2017
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)Erin A Bohula, Stephen D Wiviott, Robert P Giugliano, et al.
Circulation|May 16, 2007
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyKaren P Alexander, L Kristin Newby, Christopher P Cannon, et al.
The American Journal of Cardiology|March 11, 1999
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trialW S Weintraub, S D Culler, A Kosinski, et al.
The American Journal of Medicine|November 4, 2000
Redefining medical treatment in the management of unstable anginaE Braunwald, R M Califf, C P Cannon, et al.
American Heart Journal|April 1, 2019
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trialGregory Y H Lip, Laura Mauri, Gilles Montalescot, et al.
Circulation|May 16, 2007
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyKaren P Alexander, L Kristin Newby, Paul W Armstrong, et al.
Diabetes, Obesity & Metabolism|May 23, 2022
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitusMatthew W Segar, Ahmed A Kolkailah, Robert Frederich, et al.
American Heart Journal|April 30, 2017
Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromesGregory Ducrocq, Phillip J Schulte, Andrzej Budaj, et al.
Journal of the American College of Cardiology|November 7, 1999
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial InfarctionC M Gibson, S Murphy, I B Menown, et al.
The American Journal of Cardiology|April 14, 2012
Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendationsSeth S Martin, Thomas S Metkus, Aaron Horne, et al.
Pageof 94

Showing results (841-850 of 934) with videos related to

Sort By:
Pageof 94
Circulation|October 4, 2017
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)Erin A Bohula, Stephen D Wiviott, Robert P Giugliano, et al.
Circulation|May 16, 2007
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyKaren P Alexander, L Kristin Newby, Christopher P Cannon, et al.
The American Journal of Cardiology|March 11, 1999
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trialW S Weintraub, S D Culler, A Kosinski, et al.
The American Journal of Medicine|November 4, 2000
Redefining medical treatment in the management of unstable anginaE Braunwald, R M Califf, C P Cannon, et al.
American Heart Journal|April 1, 2019
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trialGregory Y H Lip, Laura Mauri, Gilles Montalescot, et al.
Circulation|May 16, 2007
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyKaren P Alexander, L Kristin Newby, Paul W Armstrong, et al.
Diabetes, Obesity & Metabolism|May 23, 2022
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitusMatthew W Segar, Ahmed A Kolkailah, Robert Frederich, et al.
American Heart Journal|April 30, 2017
Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromesGregory Ducrocq, Phillip J Schulte, Andrzej Budaj, et al.
Journal of the American College of Cardiology|November 7, 1999
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial InfarctionC M Gibson, S Murphy, I B Menown, et al.
The American Journal of Cardiology|April 14, 2012
Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendationsSeth S Martin, Thomas S Metkus, Aaron Horne, et al.
Pageof 94